XML 23 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows ( Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities:    
Net income $ 14,595 $ 15,448
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,193 4,996
Amortization of deferred revenue (280) (196)
Amortization of deferred financing costs 365 365
Accretion of asset retirement obligations 73 67
Deferred income taxes 25 0
(Income) loss from equity method investments (245) 229
Loss (gain) on asset disposals 12 (44)
Unit-based compensation expense 174 108
Changes in assets and liabilities:    
Accounts receivable (4,610) 5,882
Inventories and other current assets 2,814 4,559
Accounts payable and other current liabilities 2,296 2,153
Accounts receivable/payable to related parties 3,149 (7,356)
Non-current assets and liabilities, net (87) 163
Net cash provided by operating activities 23,474 26,374
Cash flows from investing activities:    
Purchases of property, plant and equipment (3,764) (1,911)
Proceeds from sales of property, plant and equipment 0 175
Equity method investment contributions (1,650) (14,819)
Net cash used in investing activities (5,414) (16,555)
Cash flows from financing activities:    
Distributions to general partner (3,994) (1,801)
Distributions to common unitholders - public (6,291) (5,592)
Distributions to common unitholders - Delek (10,252) (1,651)
Distributions to subordinated unitholders - Delek 0 (7,080)
Proceeds from revolving credit facility 69,100 84,400
Payments of revolving credit facility (69,700) (78,100)
Reimbursement of capital expenditures by Delek 3,051 209
Net cash used in financing activities (18,086) (9,615)
Net (decrease) increase in cash and cash equivalents (26) 204
Cash and cash equivalents at the beginning of the period 59 0
Cash and cash equivalents at the end of the period 33  
Cash paid during the period for:    
Interest 3,693 2,890
Non-cash investing activities:    
Decrease in accrued capital expenditures (973) (827)
Non-cash financing activities:    
Sponsor contribution of fixed assets $ 67 $ 609